{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "XM_793794.2:c.1915T; NM_016856.3:c.2019S",
          "cDNA Change": {
            "transcript": "XM_793794.2",
            "ref": "I",
            "alt": "T",
            "position": "1915"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "position_in_protein"
          },
          "Description in input context": "dLRRK(I1915T)"
        },
        {
          "HGVS": "NM_016856.3:c.2019S",
          "cDNA Change": {
            "transcript": "NM_016856.3",
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "position_in_protein"
          },
          "Description in input context": "hLRRK2(G2019S)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0001436"
  },
  "Experiment Method": [
    {
      "Assay Method": "Reporter assay",
      "Material used": {
        "Material Source": "Drosophila cells/tissues",
        "Material Name": "TH-Gal4 line (dopaminergic neurons)",
        "Description": "The study uses a GFP reporter construct to measure miRNA activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "XM_793794.2:c.1915T; NM_016856.3:c.2019S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "disrupts miRNA-mediated repression",
          "Result Description": "Increased GFP expression due to pathogenic LRRK2 variants."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Co-expression of pathogenic LRRK2 variants leads to increased reporter activity compared to wild-type."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 showing normal miRNA-mediated repression."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-expressing construct."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "Not mentioned in the abstract."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "Not mentioned in the abstract."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not explicitly mentioned in the abstract."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal miRNA-mediated repression of GFP expression.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly increased GFP expression due to LRRK2 variants disrupting miRNA function.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Reporter assays are commonly used in studying gene function and disease mechanisms."
      }
    }
  ]
}